Sarepta Gene Therapy Appears To Help Fourth Boy With Duchenne Muscular Dystrophy

An experimental gene therapy dramatically improved the ability of a young boy with Duchenne muscular dystrophy to rise from the ground or climb stairs, repeating and improving on results seen in three previous patients who received the treatment, which is being developed by Sarepta Therapeutics of Cambridge, Mass.